tiprankstipranks
Trending News
More News >
Brii Biosciences Limited (HK:2137)
:2137
Hong Kong Market

Brii Biosciences Limited (2137) Financial Statements

Compare
2 Followers

Brii Biosciences Limited Financial Overview

Brii Biosciences Limited's market cap is currently HK$1.10B. The company's EPS TTM is HK$-0.223444464; its P/E ratio is -2.73; Brii Biosciences Limited is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is HK$-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M¥ 82.22M
Gross Profit¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M¥ 82.22M
Operating Income¥ -399.50M¥ -544.30M¥ -513.85M¥ -610.48M¥ -896.97M
EBITDA¥ -392.51M¥ -168.20M¥ -503.58M¥ -602.80M¥ -890.79M
Net Income¥ -508.16M¥ -174.83M¥ -484.31M¥ -4.12B¥ -1.21B
Balance Sheet
Cash & Short-Term Investments¥ 2.33B¥ 2.66B¥ 3.00B¥ 3.35B¥ 1.05B
Total Assets¥ 2.71B¥ 3.20B¥ 3.39B¥ 3.61B¥ 1.27B
Total Debt¥ 28.02M¥ 3.16M¥ 12.66M¥ 21.62M¥ 28.33M
Net Debt¥ -975.35M¥ -486.49M¥ -1.18B¥ -2.83B¥ -1.01B
Total Liabilities¥ 100.55M¥ 125.87M¥ 234.35M¥ 300.44M¥ 3.01B
Stockholders' Equity¥ 2.66B¥ 3.12B¥ 3.19B¥ 3.34B¥ -1.74B
Cash Flow
Free Cash Flow¥ -376.12M¥ -643.62M¥ -635.57M¥ -880.49M¥ -403.72M
Operating Cash Flow¥ -372.89M¥ -594.01M¥ -496.28M¥ -879.46M¥ -403.72M
Investing Cash Flow¥ 895.47M¥ -104.35M¥ -1.43B¥ -475.76M¥ -43.65M
Financing Cash Flow¥ -9.41M¥ -10.98M¥ -3.04M¥ 3.23B¥ 657.00M
Currency in CNY

Brii Biosciences Limited Earnings and Revenue History

Brii Biosciences Limited Debt to Assets

Brii Biosciences Limited Cash Flow

Brii Biosciences Limited Forecast EPS vs Actual EPS